Novel alternatively spliced variant with a deletion of 52 BP in exon 6 of the progesterone receptor gene is observed frequently in breast cancer tissues

International Journal of Cancer

Volumn 105, Issue 2, 2003, Pages 182-185

  Hisatomi, Hisashi ^a   Kohno, Norio ^b   Wakita, Kazuyuki ^c   Nagao, Kumi ^a   Hirata, Hiroyuki ^a   Hikiji, Kazumasa ^a   Harada, Shoji ^a  

^a SRL INC   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c YODOGAWA CHRISTIAN HOSPITAL   (Japan)

Author keywords

Alternative splicing; Breast cancer; Progesterone receptor

Indexed keywords

PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ADULT; AGED; ALTERNATIVE SPLICING; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JAPAN; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0242432393     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11050     Document Type: Article

References (19)

1. Terenius L. Estrogen and progesterone binders in human and rat mammary carcinoma. Eur J Cancer 1973;9:291-4.
2. Horwitz KB, McGuire WL. Specific progesterone receptors in human breast cancer. Steroid 1975;25:497-505.
3. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 1995;55:5063-68.
4. Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB. Progesterone receptor variants found in breast cells repress transcription by wild-type receptor. Breast Cancer Res Treat 1998;48:231-41.
5. Balleine RL, Hunt SM, Clarke CL. Coexpression of alternatively spliced estrogen and Progesterone receptor transcripts in human breast cancer. J Clin Endocrinol Metab 1999;84:1370-7.
6. Nagao K, Kohno N, Wakita K, Hikiji K, Yamamoto S, Hirata H, Hisatomi H. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer. Oncol Rep 2003;10:305-8.
7. Hanke J, Brett D, Zastrow I, Aydin A, Delbruck S, Lehmann G, Luft F, Reich J, Bork P. Alternative splicing of human genes more the rule than the exception. Trends Genet 1999;15:389-90.
8. Mironov AA, Fickett JW, Gelfland MS. Frequent alternative splicing of human genes. Genome Res 1999;9:1288-93.
9. Stallings-Mann ML, Ludwiczak RL, Klinger KW, Rottman F. Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Pro Natl Acad Sci USA 1996;93:12394-9.
10. Liu W, Qian C, Francke U. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 1997:16:328-9.
11. Siffert W, Posskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-8.
12. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun 1996;228:63-8.
13. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999;8:1893-900.
14. Sugino T, Toshida K, Bolodeoku J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E, Tarin D. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 1996;69:301-6.
15. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their Relevance to etiology and pathogenesis: a review. Int J Cancer 1996;69:225-35.
16. Arai M, Shimizu S, Imai Y, Nakatsuru Y, Oda H, Oohara T, Ishikawa T. Mutations of the K-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70:390-5.
17. Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of nonfamilial breast cancers. Int J Cancer 1998;79:334-42.
18. Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC, Yu Y. ARHI is the center of allelic deletion of chromosome 1p31 in ovarian and breast cancers. Int J Cancer 2000;86:690-4.
19. Hisatomi H, Nagao K, Wakita K, Kohno N. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 2002;248:136-40.